stock views
Jump to
25 Results Found
  • Brokerages upgraded these 35 stocks in November; expect returns up to 40% Nov 20, 2020 01:47 PM IST

    Brokerages upgraded these 35 stocks in November; expect returns up to 40%

    The most noted point after September quarter earnings season was that more than 100 stocks witnessed upgrade in rating to buy from brokerages.

  • Hot Stocks | Nifty eyes new milestones; expert sees 11% upside on these 2 stocks Jan 13, 2020 08:32 AM IST

    Hot Stocks | Nifty eyes new milestones; expert sees 11% upside on these 2 stocks

    This Friday, Nifty continued its northward trajectory and with the help of complete gush, managed to clock fresh record highs beyond 12,300.

  • Hot stocks | As rally broadens focus on midcaps; 2 stocks that can give healthy returns in 3-4 weeks Dec 30, 2019 08:08 AM IST

    Hot stocks | As rally broadens focus on midcaps; 2 stocks that can give healthy returns in 3-4 weeks

    "We had a good broad-based rally in the market where few marquee large-cap names joined hands with quality mid-cap counters. It’s a sign of a healthy bull run, which we believe is likely to continue."

  • Bet on these top 11 stocks for 12-29% return as growth story likely to pick up soon Nov 04, 2019 10:01 AM IST

    Bet on these top 11 stocks for 12-29% return as growth story likely to pick up soon

    The BSE Sensex already surpassed earlier record-high and made a fresh high of 40,392.22 last week, showing over 11 percent gains from September lows.

  • Yes Bank, BHEL among 15 stocks that rose/fell the most in last week Oct 19, 2019 02:05 PM IST

    Yes Bank, BHEL among 15 stocks that rose/fell the most in last week

    The S&P BSE Mid-cap index gained 4.64 percent, S&P BSE Large-cap index rose 3.49 percent and the Small-cap Index was up 2.78 percent last week.

  • Buy or sell: Top stock trading ideas by market experts which are good short-term bets Nov 26, 2018 08:02 AM IST

    Buy or sell: Top stock trading ideas by market experts which are good short-term bets

    Rajesh Agarwal of AUM Capital recommends buying RBL Bank with stop loss at Rs 552 and target of Rs 567, Indoco Remedies with stop loss at Rs 194 and target of Rs 210 and Adani Gas with stop loss at Rs 105 and target of Rs 120.

  • Top buy & sell ideas by Ashwani Gujral,Mitessh Thakkar & Prakash Gaba for November 23 Nov 23, 2017 08:47 AM IST

    Top buy & sell ideas by Ashwani Gujral,Mitessh Thakkar & Prakash Gaba for November 23

    Ashwani Gujral of ashwanigujral.com has a buy on Rain Industries with a stop loss of Rs 315, target of Rs 332, a buy on United Breweries with a stop loss of Rs 1090, target of Rs 1150 and a buy on Sun Pharma Advanced Research with a stop loss of Rs 410, target of Rs 435.

  • Bull's Eye: Buy Sun TV, IGL, Blue Star, Havells, NIIT Tech, Apollo Hospitals Oct 11, 2017 07:58 AM IST

    Bull's Eye: Buy Sun TV, IGL, Blue Star, Havells, NIIT Tech, Apollo Hospitals

    Jay Thakkar of Anand Rathi Securities advises buying Greaves Cotton with a target of Rs 142.75.

  • Bull's Eye: Buy Escorts, Indoco Remedies, Glenmark Pharma, Voltas, Eveready Oct 09, 2017 07:59 AM IST

    Bull's Eye: Buy Escorts, Indoco Remedies, Glenmark Pharma, Voltas, Eveready

    Jay Thakkar of Anand Rathi Securities is of the view that one may sell RBL Bank Future with a target of Rs 506.

  • These 10 pharma stocks’ PE trade at a discount of over 20% to 5-year average Aug 24, 2017 09:40 AM IST

    These 10 pharma stocks’ PE trade at a discount of over 20% to 5-year average

    Moneycontrol analysed pharma stocks with a market cap of over Rs 1,000 crore. In order to find out if there are any scrips available at a reasonable valuation, we used five-year average price-to-earnings as a filter

  • Top buzzing stocks to trade on April 5 Apr 05, 2017 02:39 PM IST

    Top buzzing stocks to trade on April 5

    Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today - Neuland Labs, Titan, Cyient, Indoco Remedies, Shankara Buildpro, Ashok Leyland, TVS Motor, Tata Motors, and AB Money.

  • Don‘t expect big returns from large-cap pharma: Surajit Pal Sep 27, 2016 04:40 PM IST

    Don‘t expect big returns from large-cap pharma: Surajit Pal

    Expressing concern that drug majors are running out of cash in the US market and their generics business is shrinking, Surajit Pal of Prabhudas Lilladher said he doesn‘t expect great returns from large-cap pharma stocks.

  • Sell Indoco Remedies, Canara Bank; buy CESC: Ashwani Gujral Jul 18, 2016 03:08 PM IST

    Sell Indoco Remedies, Canara Bank; buy CESC: Ashwani Gujral

    According to Ashwani Gujral of ashwanigujral.com, one can sell Indoco Remedies and Canara Bank and buy CESC.

  • Positive on Indoco Remedies: Mahantesh Sabarad Mar 14, 2016 01:24 PM IST

    Positive on Indoco Remedies: Mahantesh Sabarad

    Mahantesh Sabarad of SBI Capital Securities has a positive view on midcap pharma including Indoco Remedies.

  • Sell Dish TV, Indoco Remedies; buy JBF Ind: Ashwani Gujral Mar 04, 2016 11:49 AM IST

    Sell Dish TV, Indoco Remedies; buy JBF Ind: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends selling Dish TV and Indoco Remedies and advises buying JBF Industries.

  • Bull's Eye: Buy Biocon, Colgate, Zee Media, Ashok Leyland Oct 15, 2015 07:55 AM IST

    Bull's Eye: Buy Biocon, Colgate, Zee Media, Ashok Leyland

    Shahina Mukadam, Independent Market Expert advises buying Zee Media Corporation with a target of Rs 24.

  • Glenmark Pharma top pick, like Ipca Lab: Sudip Bandopadhyay Aug 18, 2015 04:46 PM IST

    Glenmark Pharma top pick, like Ipca Lab: Sudip Bandopadhyay

    Sudip Bandopadhyay of Destimoney Securities is of the view that Glenmark Pharma is the top pick and likes Ipca Labs and Indoco Remedies.

  • Like Mangalam Cement, Mahindra CIE: Sudip Bandopadhyay Jul 17, 2015 04:32 PM IST

    Like Mangalam Cement, Mahindra CIE: Sudip Bandopadhyay

    Sudip Bandopadhyay of Destimoney Securities is of the view that one may prefer midcap stocks like Mangalam Cement, Mahindra CIE and Ramkrishna Forgings.

  • Indoco Remedies may touch Rs 392: Daljeet Kohli Jan 02, 2015 04:05 PM IST

    Indoco Remedies may touch Rs 392: Daljeet Kohli

    Daljeet S Kohli, Head of Research at Indianivesh Securities feels that Indoco Remedies may touch Rs 392.

  • Hold Indoco Remedies, says Manas Jaiswal Sep 09, 2014 02:36 PM IST

    Hold Indoco Remedies, says Manas Jaiswal

    Manas Jaiswal of manasjaiswal.com is of the view that one can hold Indoco Remedies as the stock has potential to test Rs 335 in next three to four trading sessions.

  • Prefer Ipca, Unichem Labs, Indoco Remedies: Sandeep Shenoy Feb 12, 2014 01:18 PM IST

    Prefer Ipca, Unichem Labs, Indoco Remedies: Sandeep Shenoy

    Sandeep Shenoy of Anand Rathi Financial Services is of the view that one may prefer Ipca Laboratories, Unichem Laboratories and Indoco Remedies from the pharma space.

  • Pick Cipla, Dr Reddys Labs: Sriram Rathi Dec 20, 2013 01:04 PM IST

    Pick Cipla, Dr Reddys Labs: Sriram Rathi

    Sriram Rathi, pharma analyst at Anand Rathi is of the view that one may pick Cipla and Dr Reddys Laboratories from largecap pharma space.

  • Bull's Eye: Buy Siemens, Tata Global, BGR Energy, UPL Nov 29, 2013 09:05 AM IST

    Bull's Eye: Buy Siemens, Tata Global, BGR Energy, UPL

    Nooresh Merani of AMSEC Research advises buying Tata Global Beverage for a target price of Rs 155 and Godrej Industries for a target price of Rs 290.

  • Invest in Indoco Remedies: Gaurav Jain Jun 16, 2011 02:05 PM IST

    Invest in Indoco Remedies: Gaurav Jain

    Gaurav Jain of Hem Securities has recommended investing in Indoco Remedies.

  • Indoco Remedies can test Rs 600: SP Tulsian Apr 08, 2011 11:31 AM IST

    Indoco Remedies can test Rs 600: SP Tulsian

    Indoco Remedies can test Rs 600, says SP Tulsian, sptulsian.com.

Sections